Jump to top menu Jump to main menu Jump to content
Research group/lab

WHO Collaborating Centre (WHO-CC) for Arbovirus and Haemorrhagic Fever Reference and Research

Our main role is to support WHO in its function of alert and response to outbreaks of emerging and dangerous pathogens of international importance, including outbreaks of arboviruses, viral haemorrhagic fevers and novel and emerging infectious diseases at the human - animal interface.

About our research group/lab

Our research

  • Early identification of outbreaks of emerging and dangerous pathogens

     In order to detect emerging and a broad range of pathogens, multiple high throughput and broad ranging protocols are in development. These include broad spectrum neutralization techniques, broad spectrum PCR approaches and fieldable sequencing of pathogens from humans, animals and vectors. Two new studies allowing collection of materials either from vaccinated patients, or patients with rare or emerging viral infections will address the lack of material for diagnostic test development and evaluation.
  • Support outbreak response operations of emerging and dangerous pathogens.

    During response operations to outbreaks of emerging and dangerous pathogens coordinated by WHO, we provide, if necessary and possible, onsite laboratory diagnostic support with staff and equipment when possible.
  • Support the development of WHO recommendations and guidelines in the context of outbreaks of Emerging and Dangerous Pathogens.

    We contribute with expert opinions and support the development, review and editing of specialised or generic WHO recommendations, fact sheets and guidelines documents related to merging and dangerous pathogens. Examples include the new WHO yellow fever virus laboratory manual (under development, 2021), the development of a target product profile (TPP) for yellow fever virus and SARS-CoV-2, the Interim guidance and handbook on genomic sequencing of SARSCoV-2 etc.
  • Contribute in relevant WHO technical consultations on emerging and dangerous pathogens and contribute with training national and regional collaborating laboratories concerning diagnostic, scientific, medical and epidemiological activities.

    As a designated SARS-CoV-2 reference laboratory, both nationally and internationally we have contributed with training, consultation, data and advice to collaborating laboratories concerning diagnostic, scientific, medical and epidemiological activities.
 

Our projects

Examples of our main achievements and activities include: 

  • Constant monitoring of Usutu and West Nile virus
  • Diagnostics and public health response involvement for imported Lassa virus cases 
  • Diagnostics of an imported yellow fever patient  
  • Investigation of rabies cases in Qatar 
  • Support in investigations of Zika virus in Surinam and Brazil; 
  • The operation of mobile laboratories during the Ebola outbreak in West Africa; 
  • The contributions to identify the cause of MERS coronavirus and involvement in the studies unravelling the role of camels as source; 
 

During the SARS-CoV-2:

Key Publications

Collaborations

Collaboration within Erasmus MC:

Collaboration outside of Erasmus MC:

  • (WHO)- World Health Organization
  • (EYE)- Eliminate yellow fever epidemics
  • EVD-LabNet- Emerging Viral Diseases-Expert Laboratory Network (europa.eu)
  • ECDC- European Centre for Disease Prevention and Control
  • VEO- Versatile emerging infectious disease observatory
  • ECRAID- European Clinical Research Alliance on Infectious Diseases 
  • SHARP- Strengthened International HeAlth Regulations and Preparedness in the EU 
  • PDPC- Pandemic & Disaster Preparedness Center
  • GGD- Rotterdam Rijnmond
  • RIVM- Rijksinstituut voor Volksgezondheid en Milieu
 

Our team

For enquires please email either email viroscience@erasmusmc.nl and you will be put in touch with the right person or r.molenkamp@erasmusmc.nl directly.

See also the Global database of the WHO Collaborating Centres:
https://apps.who.int/whocc/PortalV9.aspx

Our team:

Drs. J. Velzing
Consultant business management, department Clinical Virology

Principal Investigators

Postdocs